SynthesisFrontiers in immunology2022

Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders.

Dennis D Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.